Insights

Innovative Cell Therapy Longeveron specializes in developing groundbreaking cellular therapies derived from mesenchymal stem cells, targeting aging-related conditions and rare pediatric diseases, presenting opportunities to collaborate with healthcare providers seeking regenerative medicine solutions.

Expanding Clinical Pipeline With ongoing Phase 2b trials for hypoplastic left heart syndrome and promising results in Alzheimer’s and frailty indications, there is a strategic opening for partnerships in clinical research, medical device integration, and specialty healthcare markets.

Robust Funding Growth Recent financing rounds amounting to up to $45 million highlight the company’s strong investor confidence, indicating potential for future co-investment opportunities, joint ventures, or public-private collaborations aimed at scaling regenerative treatments.

Leadership & Visibility The appointment of new executive leadership and participation in high-profile industry events signal an evolving company poised for growth, providing networking opportunities to connect with key decision-makers and healthcare innovators.

Market Focus & Trends Longeveron’s alignment with the growing aging population and the increasing demand for therapies enhancing healthspan suggest a high market potential, particularly in long-term care, elder health management, and personalized regenerative medicine solutions.

Longeveron Inc Tech Stack

Longeveron Inc uses 8 technology products and services including Cloudflare, Font Awesome, JSON-LD, and more. Explore Longeveron Inc's tech stack below.

  • Cloudflare
    Content Management System
  • Font Awesome
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • WP Engine
    Platform As A Service
  • HSTS
    Security
  • reCAPTCHA
    Security

Media & News

Longeveron Inc's Email Address Formats

Longeveron Inc uses at least 1 format(s):
Longeveron Inc Email FormatsExamplePercentage
FLast@longeveron.comJDoe@longeveron.com
97%
First@longeveron.comJohn@longeveron.com
3%

Frequently Asked Questions

Where is Longeveron Inc's headquarters located?

Minus sign iconPlus sign icon
Longeveron Inc's main headquarters is located at 1951 Northwest 7th Avenue Miami, Florida United States. The company has employees across 2 continents, including North AmericaEurope.

What is Longeveron Inc's phone number?

Minus sign iconPlus sign icon
You can contact Longeveron Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Longeveron Inc's stock symbol?

Minus sign iconPlus sign icon
Longeveron Inc is a publicly traded company; the company's stock symbol is LGVN.

What is Longeveron Inc's official website and social media links?

Minus sign iconPlus sign icon
Longeveron Inc's official website is longeveron.com and has social profiles on LinkedIn.

What is Longeveron Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Longeveron Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Longeveron Inc have currently?

Minus sign iconPlus sign icon
As of June 2026, Longeveron Inc has approximately 43 employees across 2 continents, including North AmericaEurope. Key team members include Chief Medical Officer/ Global Development Lead: N. A.Vice President Of Quality: E. B.Vp Corporate Controller: M. W.. Explore Longeveron Inc's employee directory with LeadIQ.

What industry does Longeveron Inc belong to?

Minus sign iconPlus sign icon
Longeveron Inc operates in the Biotechnology Research industry.

What technology does Longeveron Inc use?

Minus sign iconPlus sign icon
Longeveron Inc's tech stack includes CloudflareFont AwesomeJSON-LDLodashMicrosoftWP EngineHSTSreCAPTCHA.

What is Longeveron Inc's email format?

Minus sign iconPlus sign icon
Longeveron Inc's email format typically follows the pattern of FLast@longeveron.com. Find more Longeveron Inc email formats with LeadIQ.

When was Longeveron Inc founded?

Minus sign iconPlus sign icon
Longeveron Inc was founded in 2014.

Longeveron Inc

Biotechnology ResearchFlorida, United States11-50 Employees

We are a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions. Our lead investigational product is laromestrocel (Lomecel-B™), which is derived from culture-expanded mesenchymal stem cells (MSCs) that are sourced from bone marrow of young healthy adult donors. We believe that by using the same cells that promote tissue repair, organ maintenance, and immune system function, we can develop safe and effective therapies for some of the most difficult diseases and conditions associated with aging.
Our clinical development programs have delivered several positive initial results across 5 clinical trials in 3 indications:  Phase 1 & 2 in Alzheimer’s Disease, Phase 1 & 2 in Aging-related Frailty, Phase 1 in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease.  We are currently conducting a pivotal Phase2b clinical trial in HLHS. Our mission is to advance laromestrocel (Lomecel-B™) and other cell-based product candidates into pivotal trials, with the goal of achieving regulatory approvals, subsequent commercialization and broad use by the healthcare community.
Our philosophy is that healthy aging can be improved through regenerative medicine approaches. Life expectancy has substantially increased over the past century as a result of medical and public health advancements. However, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging – a period known as healthspan. As we age, we experience a profound decline, in both number and function, in our own MSCs, a decrease in immune system function, decline in blood vessel functioning, chronic inflammation and other issues. Our clinical data suggest that laromestrocel (Lomecel-B™) addresses these conditions through multiple mechanisms of action, or MOAs, that target key aging-related processes

Section iconCompany Overview

Headquarters
1951 Northwest 7th Avenue Miami, Florida United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LGVN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M

    Longeveron Inc's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Longeveron Inc's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.